1. Tocopheryl Phosphate Inhibits Rheumatoid Arthritis-Related Gene Expression In Vitro and Ameliorates Arthritic Symptoms in Mice.
- Author
-
Hama S, Kirimura N, Obara A, Takatsu H, and Kogure K
- Subjects
- Animals, Arthritis, Rheumatoid chemically induced, Cytokines biosynthesis, Glucans toxicity, Humans, Matrix Metalloproteinase 13 biosynthesis, Matrix Metalloproteinase 3 biosynthesis, Mice, alpha-Tocopherol pharmacology, Antirheumatic Agents pharmacology, Arthritis, Rheumatoid drug therapy, Arthritis, Rheumatoid metabolism, Gene Expression Regulation drug effects, alpha-Tocopherol analogs & derivatives
- Abstract
Anti-rheumatoid arthritis (RA) effects of α-tocopherol (α-T) have been shown in human patients in a double-blind trial. However, the effects of α-T and its derivatives on fibroblast-like synoviocytes (FLS) during the pathogenesis of RA remain unclear. In the present study, we compared the expression levels of genes related to RA progression in FLS treated with α-T, succinic ester of α-T (TS), and phosphate ester of α-T (TP), as determined via RT-PCR. The mRNA levels of interleukin (IL)-6, tumor necrosis factor-α (TNF-α), matrix metalloproteinase (MMP)-3, and MMP-13 were reduced by treatment with TP without cytotoxicity, while α-T and TS did not show such effects. Furthermore, intraperitoneal injection of TP ameliorated the edema of the foot and joint and improved the arthritis score in laminarin-induced RA model mice. Therefore, TP exerted anti-RA effects through by inhibiting RA-related gene expression.
- Published
- 2022
- Full Text
- View/download PDF